March 12, 2008
View Full PaperEGFR Antagonists in Cancer Treatment
Key Points
Key points are not available for this paper at this time.
Abstract
Functional activation of growth factors and receptors of the epidermal growth factor receptor (EGFR) family occurs in most epithelial-cell cancers, rendering EGFR a target for cancer treatment. This article discusses the mechanisms of action of EGFR inhibitors, their anticancer activity, and clinical issues concerning their use in the treatment of patients with cancer.